ROAD Q1 2026 Earnings Strong EPS Beat Drives Stock Higher NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 CNF Q4 2023 Earnings Massive EPS Surprise Driven by Exceptional Profitability BlackRock BLK Q1 2026 Earnings EPS Beat Drives Modest Stock Gain ECL Q1 2026 Earnings EPS Misses Estimates Modestly Stock Rises on Operational Strength IAUX Q1 2026 Earnings Narrower Loss Beats Expectations as Development Progress Continues